Flyvbjerg A, Nielsen S, Sheikh M I, Jacobsen C, Orskov H, Christensen E I
Institute of Experimental Clinical Research, Aarhus Kommunehospital, Denmark.
Am J Physiol. 1993 Nov;265(5 Pt 2):F624-33. doi: 10.1152/ajprenal.1993.265.5.F624.
The aim of the present study was to quantify and compare the luminal and basolateral binding and uptake of 125I-labeled insulin-like growth factor I (IGF-I) by means of 1) isolated, perfused, proximal tubules combined with electron microscope autoradiography and 2) luminal and basolateral membrane vesicles from rabbit proximal tubules. 125I-IGF-I was added to isolated perfused proximal tubules for 30 min in concentrations of 1.6-3.9 micrograms/l to either the perfusate or the bath. The luminal and basolateral uptake in 30 min averaged 447 and 410 fg/mm, respectively. About 20% of the luminally absorbed IGF-I was digested. Addition of excess unlabeled IGF-I (10(-7) M) to the bath produced complete inhibition of the basolateral binding/uptake, whereas no inhibition of the luminal uptake was seen. Electron microscope autoradiography showed that IGF-I after luminal endocytic uptake to a large extent was transported into lysosomes. After basolateral exposure the major portion of the grains was found over the basolateral cell membrane; however, a significant amount was located over endocytic vacuoles and lysosomes in both apical and basal parts of the cells. In both luminal and basolateral membrane vesicles, single-class, high-affinity binding sites for IGF-I were found with dissociation constants of 6.3 and 5.7 nM, respectively. Specific binding capacities averaged 2.7 and 25.7 pmol IGF-I/mg protein in luminal and basolateral vesicles. The biochemical data suggest an asymmetric distribution of specific IGF-I receptors in the luminal and basolateral membranes, with a greater abundance of receptors in the latter. The extensive basolateral endocytic binding/uptake of IGF-I compared with that of the luminal in isolated perfused tubules differs considerably from the processing of other peptide hormones.
本研究的目的是通过以下两种方法来定量和比较125I标记的胰岛素样生长因子I(IGF-I)在管腔侧和基底外侧的结合及摄取情况:1)分离、灌注近端小管并结合电子显微镜放射自显影;2)来自兔近端小管的管腔侧和基底外侧膜囊泡。将125I-IGF-I以1.6 - 3.9微克/升的浓度添加到分离灌注的近端小管的灌注液或浴液中30分钟。30分钟内管腔侧和基底外侧的摄取量平均分别为447和410飞克/毫米。管腔侧吸收的IGF-I约20%被消化。向浴液中添加过量未标记的IGF-I(10^(-7) M)可完全抑制基底外侧的结合/摄取,而管腔侧摄取未见抑制。电子显微镜放射自显影显示,管腔侧通过内吞摄取的IGF-I在很大程度上被转运到溶酶体中。基底外侧暴露后,大部分银粒位于基底外侧细胞膜上;然而,在细胞顶端和基部的内吞泡和溶酶体上也有大量银粒。在管腔侧和基底外侧膜囊泡中均发现了IGF-I的单类高亲和力结合位点,解离常数分别为6.3和5.7纳摩尔。管腔侧和基底外侧囊泡中特异性结合容量平均分别为2.7和25.7皮摩尔IGF-I/毫克蛋白。生化数据表明,IGF-I特异性受体在管腔侧和基底外侧膜中呈不对称分布,后者受体丰度更高。与管腔侧相比,分离灌注小管中基底外侧对IGF-I的广泛内吞结合/摄取与其他肽类激素的处理方式有很大不同。